DOI QR코드

DOI QR Code

Low Lung Cancer Resection Rates in a Tertiary Level Thoracic Center in Nepal - Where Lies Our Problem?

  • Thapa, Bibhusal (ManMohan Cardio-Thoracic Vascular and Transplant Center) ;
  • Sayami, Prakash (ManMohan Cardio-Thoracic Vascular and Transplant Center)
  • 발행 : 2014.01.15

초록

Background: Resection rates of lung cancer are low in general and especially in countries like Nepal. Advanced stage at presentation and poor general condition of the patient are the usual causes. Materials and Methods: In this prospective observational study, one hundred cases of lung cancer who presented at the Thoracic Surgery Unit between October 2011 and October 2012 were included. Results: Those aged in the $6^{th}$ and $7^{th}$ decades together accounted for 72/100 patients. The male to female ratio was 2:1. There was a mean-$29.2{\pm}14.2$ pack yrs smoking history with only five non-smokers. Seventy-six patients presented with locally advanced disease while 21 had metastases. Only three had local disease. The average time between onset of symptoms to first contact with a doctor was $2.3{\pm}5.3$ months (range: 0-35.6 months). Average time between first contact to referral was $50.4{\pm}65.7$ days (range-0-365). Only three patients were resected, one after neo-adjuvant chemotherapy. Advanced disease was the cause of unresectability in 95 cases. One of three patients with local disease had pulmonary functions allowing the warranted resection. $N_2$ disease with $T_{1-3}$ on CT scan was found in 47. Three of these patients underwent mediastinoscopy and all confirmed uninvolved $N_2$. Conclusions: Lung resection rates in our center remain low. Late presentation leading to advanced disease and poor pulmonary reserves preclude resection in most cases. More liberal use of mediastinal staging and better assessment of pulmonary functions may allow us to improve resection rates.

키워드

참고문헌

  1. Billing JS, Wells FC (1996). Delays in the diagnosis and surgical treatment of lung cancer. Thorax, 51, 903-6. https://doi.org/10.1136/thx.51.9.903
  2. Bozcuk H, Martin C (2001). Does treatment delay affect survival in non-small cell lung cancer? A retrospective analysis from a single UK centre. Lung Cancer, 34, 243-52. https://doi.org/10.1016/S0169-5002(01)00247-1
  3. Chandra S, Mohan A, Guleria R, Singh B, Yadav P (2009). Delays during the diagnostic evaluation and treatment of lung cancer. Asian Pac J Cancer Prev, 10, 453-6.
  4. Coleman MP, Forman D, Bryant H (2011). Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995e2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet, 377, 127-38. https://doi.org/10.1016/S0140-6736(10)62231-3
  5. Crapo RO, Morris AH (1989). Pulmonary function testing: sources of error in measurement and interpretation. South Med J, 82, 875-9. https://doi.org/10.1097/00007611-198907000-00020
  6. Crawford SM, Sauerzapf V, Haynes R, Zhao H, Forman D et al (2009). Social and geographical factors affecting access to treatment of lung cancer. Br J Cancer, 101, 897-901. https://doi.org/10.1038/sj.bjc.6605257
  7. Damhuis RAM, Schutte PR (1995). Resection rates and postoperative mortality in 7,899 patients with lung cancer. Eur Respir J, 9, 8-11.
  8. Dransfield MT, Lock BJ, Garver RI Jr (2006). Improving the lung cancer resection rate in the US Department of Veterans Affairs Health System. Clin Lung Cancer, 7, 268-72. https://doi.org/10.3816/CLC.2006.n.005
  9. Ellis PM, Vandermeer R (2011). Delays in the diagnosis of lung cancer. J Thorac Dis, 3, 183-8.
  10. Jensen AR, Mainz J, Overgaard J (2002). Impact of delay on diagnosis and treatment of primary lung cancer. Acta Ontol, 24, 147-52.
  11. Graham EA, Singer JJ (1933). Successful removal of an entire lung for carcinoma of the bronchus. J Am Med Assoc, 101, 1371-3. https://doi.org/10.1001/jama.1933.02740430017005
  12. Kerr KM, Lamb D,Wathen CG, Walker WS, Douglas NJ (1992). Pathological assessment of mediastinal lymph nodes in lung cancer: implications for non-invasive mediastinal staging. Thorax, 47, 337-41. https://doi.org/10.1136/thx.47.5.337
  13. Khakwani A, Rich AL, Powell HA, et al (2013). Lung cancer survival in England: trends in non-small-cell lung cancer survival over the duration of the National Lung Cancer Audit. Br J Cancer, 109, 2058-65. https://doi.org/10.1038/bjc.2013.572
  14. Margolis ML, Montoya FJ, Palma WR Jr (1997). Pulmonary function tests: comparison of 95th percentile-based and conventional criteria of normality. South Med J, 90, 1187-91. https://doi.org/10.1097/00007611-199712000-00005
  15. Myrdal G, Lambe M, Hillerdal G (2004). Effect of delays on prognosis in patients with non-small cell lung cancer. Thorax, 59, 45-9.
  16. Olsen GN (1989). The evolving role of exercise testing prior to lung resection. Chest, 95, 218. https://doi.org/10.1378/chest.95.1.218
  17. Petty TL (2001). Simple office spirometry. Clin Chest Med, 22, 845-59. https://doi.org/10.1016/S0272-5231(05)70070-8
  18. Riaz SP, Luchtenborg M, Jack RH, et al (2012). Variation in surgical resection for lung cancer in relation to survival: population-based study in England 2004-2006. Eur J Cancer, 48, 54-60.
  19. Rich AL, Tata LJ, Free CM, Stanley RA, et al (2011). Inequalities in outcomes for non-small cell lung cancer: the influence of clinical characteristics and features of the local lung cancer service. Thorax. 66, 1078-84. https://doi.org/10.1136/thx.2011.158972
  20. Sayami P, Singh BM, Koirala B, Sharma GP (1997). Surgery of lung cancer in Tribhuvan University Teaching Hospital. JNMA, 35, 182-5.
  21. Win T, Jackson A, Sharples L (2005). Relationship between pulmonary function and lung cancer surgical outcome. Eur Respir J, 25, 594. https://doi.org/10.1183/09031936.05.00077504
  22. Wouters MW, Siesling S, Jansen-Landheer ML, et al (2010). Variation in treatment and outcome in patients with nonsmall cell lung cancer by region, hospital type and volume in the Netherlands. Eur J Surg Oncol, 36, 83-92. https://doi.org/10.1016/j.ejso.2010.06.020

피인용 문헌

  1. Ethnic Variation in Consumption of Traditional Tobacco Products and Lung Cancer Risk in Nepal vol.16, pp.14, 2015, https://doi.org/10.7314/APJCP.2015.16.14.5721
  2. Malignant Neoplasm Burden in Nepal - Data from the Seven Major Cancer Service Hospitals for 2012 vol.16, pp.18, 2016, https://doi.org/10.7314/APJCP.2015.16.18.8659